Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Closed to Accrual

Canadian Cancer Trials Group CEC.3 (NCCTG N107C) - A Phase III Study of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease - will soon meet its accrual goal and was closed as of December 18, 2015 to new patient pre-registrations.

Thank you to all participating centres, staff and patients for your participation on this trial!